J Christopher Phelan

Title: J Christopher Phelan: Innovator in Constrained Helical Peptides

Introduction

J Christopher Phelan is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the development of constrained helical peptides. His work has implications for the prevention of viral infections, showcasing the intersection of innovation and healthcare.

Latest Patents

Phelan holds a patent for "Constrained helical peptides and methods of making same." This patent includes cyclized peptides with a constrained region having an α-helical conformation. The constrained helical peptides feature amino acid sequences derived from HIV gp41, which are instrumental in preparing antibodies that prevent viral membrane fusion. Additionally, the patent outlines methods for synthesizing these cyclized peptides.

Career Highlights

J Christopher Phelan is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to groundbreaking research in the field of therapeutic peptides.

Collaborations

Phelan has collaborated with esteemed colleagues, including Andrew C Braisted and J Kevin Judice. These partnerships have fostered a collaborative environment that enhances the research and development of novel therapeutic solutions.

Conclusion

J Christopher Phelan's contributions to the field of constrained helical peptides exemplify the vital role of innovation in addressing health challenges. His work continues to inspire advancements in biochemistry and therapeutic development.